Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: Initial results from the cryo on-line data registry

Prostate

Volumn 75, Issue 1, 2015, Pages 1-7

  Li, Yong Hong ^a,b   Elshafei, Ahmed ^a   Agarwal, Gautum ^c   Ruckle, Herbert ^d   Pow Sang, Julio ^c   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d LOMA LINDA UNIVERSITY   (United States)

Author keywords

Cryoablation; Focal therapy; Prostate cancer; Radiotherapy; Salvage

Indexed keywords

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CRYOABLATION; CRYOTHERAPY; HUMAN; HUMAN TISSUE; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSTATE BIOPSY; PROSTATE CANCER; SEXUAL INTERCOURSE; URINE RETENTION; CRYOSURGERY; DISEASE FREE SURVIVAL; MIDDLE AGED; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; REGISTER; SALVAGE THERAPY; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CRYOSURGERY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATIC NEOPLASMS; REGISTRIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84918815512     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22881     Document Type: Article

References (25)

1. Jani AB, Johnstone PA, Liauw SL, Master VA, Rossi PJ. Prostate cancer modality time trend analyses from 1973 to 2004: A Surveillance, Epidemiology, and End Results registry analysis. Am J Clin Oncol 2010; 33: 168-172.
2. Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007; 67: 327-333.
3. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR; Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: Likelihood, patterns of care, and outcomes. Cancer 2008; 112: 307-314.
4. Zietman AL, Bae K, Slater JD, Shipley WU, Efstathiou JA, Coen JJ, Bush DA, Lunt M, Spiegel DY, Skowronski R, Jabola BR, Rossi CJ. Randomized trial comparing conventional-dose with highdose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from proton radiation oncology group/American college of radiology 95-09. J Clin Oncol 2010; 28: 1106-1111.
5. Taylor LG, Canfield SE, Du XL. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 2009; 115: 2388-2399.
6. Gotto GT, Yunis LH, Vora K, Eastham JA, Scardino PT, Rabbani F. Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 2010; 184: 136-142.
7. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, Katz A, Pisters L, Rukstalis D, Shinohara K, Thrasher JB. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008; 180: 1993-2004.
8. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation: Initial results from the cryo on-line data registry. J Urol 2008; 180: 559-563.
9. de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, Gill IS, Ukimura O. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int 2013; 112: 298-307.
10. Eisenberg ML, Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology 2008; 72: 1315-1318.
11. Wenske S, Quarrier S, Katz AE. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: Long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol 2013; 64: 1-7.
12. Bomers JG, Yakar D, Overduin CG, Sedelaar JP, Vergunst H, Barentsz JO, de Lange F, Fütterer JJ. MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. Radiology 2013; 268: 451-460.
13. Spiess PE, Levy DA, Mouraviev V, Pisters LL, Jones JS. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: A novel risk stratification model. BJU Int 2013; 112: E256-261.
14. Spiess PE, Levy DA, Pisters LL, Mouraviev V, Jones JS. Outcomes of salvage prostate cryotherapy stratified by pretreatment PSA: Update from the COLD registry. World J Urol 2013; 31: 1321-1325.
15. Ritch CR, Katz AE. Prostate cryotherapy: Current status. Curr Opin Urol 2009; 19: 177-181.
16. Valerio M, Ahmed HU, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R, Nguyen PL, Trachtenberg J, Polascik TJ. The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review. Eur Urol 2013; http: //dx.doi.org/ 10.1016/j.eururo.2013.05.048. [Epub ahead of print].
17. Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: A report from the national Cryo On-Line Database (COLD) Registry. BJU Int 2012; 109: 1648-1654.
18. Budäus L, Bolla M, Bossi A, Cozzarini C, Crook J, Widmark A, Wiegel T. Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature. Eur Urol 2012; 61: 112-127.
19. Chade DC, Eastham J, Graefen M, Hu JC, Karnes RJ, Klotz L, Montorsi F, van Poppel H, Scardino PT, Shariat SF. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: A systematic review of the literature. Eur Urol 2012; 61: 961-971.
20. Masterson TA, Stephenson AJ, Scardino PT, Eastham JA. Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology 2005; 66: 623-626.
21. Anastasiadis AG, Sachdev R, Salomon L, Ghafar MA, Stisser BC, Shabsigh R, Katz AE. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol 2003; 129: 676-682.
22. Leibovici D, Chiong E, Pisters LL, Guo CC, Ward JF, Andino L, Prokhorova IN, Troncoso P. Pathological characteristics of prostate cancer recurrence after radiation therapy: Implications for focal salvage therapy. J Urol 2012; 188: 98-102.
23. Bianco FJ Jr, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 448-453.
24. Shelley MD, Kumar S, Wilt T, Staffurth J, Coles B, Mason MD. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. Cancer Treat Rev 2009; 35: 9-17.
25. Grossgold E, Given R, Ruckle H, Jones JS. Does neoadjuvant androgen deprivation therapy before primary whole gland cryoablation of the prostate affect the outcome? Urology 2014; 83: 379-384.